Published by ChinaMNC · Xiao

China’s Health‑System Reforms: What Foreign Founders Should Know

A practical overview of China’s health‑sector priorities, drawn from official sources, and how they affect company registration and operations for foreign entrepreneurs.

Why Health‑System Reform Matters for Foreign Founders in China

For foreign entrepreneurs registering or operating a company in China, understanding the direction of the country’s health‑sector reforms is not just academic. Public health priorities shape regulatory expectations, insurance rules, and business‑environment stability. Drawing on an official government summary of China’s health‑sector development, this article highlights the facts most relevant to foreign founders — without speculation or invented statistics.

Key Policy Milestones

China’s approach to health has evolved through a series of documented decisions:

• In 2016, a national health conference set a new work guideline, shifting the focus from treating disease to centering on people’s health. The “Healthy China 2030” plan was subsequently issued as a roadmap.
• In 2019, the Basic Medical Health and Promotion Law was enacted — the first foundational, comprehensive law in this field.
• Top‑level design has progressed from concept to system‑building, embedding health commitments into broader national development goals.

These milestones signal a long‑term policy commitment. For foreign founders, this continuity can inform decisions about sectors such as healthcare services, medical devices, and health‑related consumer products.

Public Health Achievements Relevant to Business

Official data show measurable improvements in population health, which indirectly affect labor force health and healthcare demand:

• Average life expectancy reached 79.25 years in 2025.
• Infant mortality fell to 3.8 per thousand, and maternal mortality to 13.4 per 100,000 — recognized by the World Health Organization as a high‑performing country for maternal and child health.
• Premature mortality from major chronic diseases dropped to 13.8%.
• Malaria has been eliminated; tuberculosis prevalence has entered the low‑intermediate range globally for the first time.
• Residents’ health literacy rose to 33.69%.
• Student myopia rates declined for five consecutive years, reaching 49.9% in 2025 — a cumulative drop of 3.7 percentage points from 2018.

These outcomes reflect a health system that is expanding access and prevention. For companies in health‑related industries, they indicate a growing market and a population with rising health awareness.

Healthcare Infrastructure and Access

China has built the world’s largest systems for medical services, traditional medicine, disease prevention and control, and medical security. Specific initiatives include:

• Support for 125 national regional medical centers, with 75% located in central and western regions where quality resources are relatively scarce.
• 2199 counties (cities, districts) are building tight‑knit county medical communities, essentially covering all counties and county‑level cities.
• Over 90% of residents can access nearby medical and health services within 15 minutes.
• All counties with a population over 100,000 can provide hemodialysis services; secondary and tertiary public general hospitals offer pediatric services.
• Primary care accounts for over 50% of total national diagnoses and treatments.
• There are 42,200 traditional Chinese medicine clinics in primary healthcare institutions, and 80% of township health centers and community health service centers can apply appropriate TCM techniques.

For foreign founders, this infrastructure means that employees and operations outside major cities can increasingly rely on local healthcare access — a factor in site selection and workforce planning.

Reform of the Medical Insurance and Drug Systems

A series of systemic reforms aim to balance cost, quality, and access:

• The share of out‑of‑pocket health expenditure fell to 27.1% of total health spending.
• Reforms include removing the drug‑markup mechanism, establishing modern public hospital management, centralized volume‑based procurement of drugs and consumables, adjusting medical service prices, advancing hierarchical diagnosis and treatment, improving medical insurance payment methods, implementing the national essential medicines system, and strengthening general practitioner teams.
• The goal “major illnesses treated within the province, general illnesses at city/county level, and common illnesses at the grassroots” is being pursued.
• The experience of Sanming, Fujian province — where drug prices dropped, insurance reimbursement rose, and patient convenience improved — has been replicated nationwide.

These changes affect how healthcare is financed and delivered. Foreign companies in pharmaceuticals, medical devices, or health insurance should monitor these evolving rules.

Implications for Company Registration and Operations

While the source text does not detail foreign investment rules, the health‑sector direction offers practical context:

• Regulatory environment: The emphasis on primary care and public health may create opportunities in telemedicine, health IT, and preventive services — but foreign founders must check sector‑specific licensing requirements.
• Employee benefits: As public health insurance coverage and efficiency improve, mandatory social insurance contributions remain a key cost consideration for employers.
• Local partnerships: The growth of county medical communities and regional centers could open avenues for collaboration with local healthcare providers, subject to relevant regulations.
• Workforce health: Improved population health indicators may support productivity, but companies should still design workplace health programs in line with local norms.

Foreign founders should always verify current legal and tax requirements with qualified professionals, as policies are updated regularly.

Conclusion

China’s health‑sector reforms are broad and sustained, with clear official targets and achievements. For foreign entrepreneurs, these developments shape the business environment in healthcare and beyond. Staying informed helps in making sound decisions about registration, operations, and sector focus.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.

For assistance with registering and operating a company in China, foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535.